Low-grade B-cell Lymphoma

• CLINICAL_TRIALS trial_result · 2022-09-22
  Clinical Trial Update: In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy [Phase 1, Phase 2]

  Phase 1/2 trial evaluating intratumoral Flt3L plus Poly-ICLC with low-dose radiotherapy as an in situ vaccine for low-grade B-cell lymphoma;…

• CLINICAL_TRIALS trial_result · 2016-09-22
  Clinical Trial Update: Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203) [Phase 2, Phase 3]

  A Phase 2/3 trial comparing Rituximab plus standard CHOP versus Rituximab plus bi-weekly CHOP in untreated stage III/IV low-grade B-cell lym…

• CLINICAL_TRIALS trial_result · 2016-05-12
  Clinical Trial Update: Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer [Phase 1, Phase 2]

  Phase 1/2 study evaluating a four-drug regimen (pentostatin, cyclophosphamide, rituximab, mitoxantrone) in patients with chronic lymphocytic…

• CLINICAL_TRIALS trial_result · 2014-10-06
  Clinical Trial Update: VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas [Phase 1, Phase 2]

  Phase 1/2 trial of VTX-2337 in combination with radiotherapy for low-grade B-cell lymphoma was terminated with results posted in 2014.

• CLINICAL_TRIALS trial_result · 2012-04-17
  Clinical Trial Update: Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies [Phase 2]

  Phase 2 dosimetry/validation study of 131Iodine-Anti B1 (murine) radioimmunotherapy in chemotherapy-refractory low-grade B-cell lymphomas, i…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.